Lilly's profit doubled in the fourth quarter, driven by its diabetes and obesity treatments Mounjaro and Zepbound, while ...
Lilly expects full-year earnings in the range of $22.50 to $24 per share, with revenue in the range of $58 billion to $61 billion. This story was generated by Automated Insights ( ...
WISH-TV on MSN9d
Deep dive on DeepSeek: Business Insider debriefs DaybreakDeepSeek, a Chinese AI startup, is disrupting the tech world with its high performance at lower prices, affecting Wall Street ...
The stock market opened with steep losses Monday in the wake of President Donald Trump’s aggressive new tariffs on Canadian, ...
GM, Ford and Stellantis stock plunged in initial trading Monday in light of a pending trade war. But Wall Street showed some ...
Global markets buckled up for a turbulent session Monday after Trump launched a trade war with sweeping tariffs on Canada, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback